Mismatch for the Minor Histocompatibility Antigen HA-2 and GVHD Occurrence in HLA-A*0201-positive Tunisian Recipients of HSCs

REFERENCES

• Behar, E., Chao, N. J., Hiraki, D. D., Krishnaswamy, S., Brown, B. W., Zehnder, J. L., (1996). Polymorphisms of adhesion molecule CD31 and its role in acute graft-versus-host disease. New Engl. J. Med.. 334:286–291.
   PubMed Web of Science ®Google Scholar
• Cavanagh, G., Chapman, C. E., Carter, V., Dickinson, A. M., Middleton, P. G. (2005). Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation. Transplantation 79:602–605.
   PubMed Web of Science ®Google Scholar
• Den Haan, J. M., Sherman, N. E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J. W., (1995). Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476.
   PubMed Web of Science ®Google Scholar
• Eisner, M. D., August, C. S. (1995). Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone Marrow Transplant. 15:663–668.
   PubMed Web of Science ®Google Scholar
• El-Chennawi, F. A., Kamel, H. A., Mosaad, Y. M., El-Sherbini, S. M., El-Billey, N. A. (2006). Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 11:227–234.
   PubMed Web of Science ®Google Scholar
• Falkenburg, F., Van de Corput, F., Marijt, E. W. A., Willemze, R. (2003). Minor histocompatibility antigens in human stem cell transplantation. Exper. Haematol. 31:743–751.
   PubMed Web of Science ®Google Scholar
• Ferrara, J. L., Levine, J. E., Reddy, P., Holler, E. (2009). Graft-versus-host disease. Lancet 373:1550–1561
   PubMed Web of Science ®Google Scholar
• Gallardo, D., Aróstegui, J. I., Balas, A., Torres, A., Caballero, D., Carreras, E., (2001). Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br. J. Haematol. 114:931–936.
   PubMed Web of Science ®Google Scholar
• Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J. H. F., Vossen, J., (1996). Mismatch of minor histocompatibility antigen between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New Engl. J. Med. 334:281–285.
   PubMed Web of Science ®Google Scholar
• Gribben, J. G. (2008). Stem cell transplantation in chronic lymphocytic leukemia. Biol. Blood Marrow Transplant. 15:53–58.
   Web of Science ®Google Scholar
• Hambach, L., Spierings, E., Goulmy, E. (2007). Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens. Best Pract. Res. Clin. Haematol. 20:171–187.
   PubMed Web of Science ®Google Scholar
• Hwang, W. Y. K., Ong, S. Y. (2009). Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: Current options and future potential. Ann. Acad. Med. Singapore 38:340–345.
   PubMed Web of Science ®Google Scholar
• Malarkannan, S., Regunathan, J., Timler, A. M. (2005) Minor Histocompatibility Antigens: Molecular targets for immunomodulation in tissue transplantation and tumor therapy. Clin. Appl. Immunol. Rev. 5:95–109.
   Google Scholar
• Martin, P. J. (1997). How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation? Bone Marrow Transplant. 20:97–100.
   PubMedGoogle Scholar
• Miklos, D. B., Kim, H. T., Miller, K. H., Guo, L., Zorn, E., Lee, S. J., (2005). Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 105:2973–2978.
   PubMed Web of Science ®Google Scholar
• Park, M. J., Choi, H. B., Jang, J. P., Kim, H. J., Kim, Y. J., Eom, K. S., (2007). Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT. Bone Marrow Transplant. 40:723–728.
   PubMed Web of Science ®Google Scholar
• Przepiorka, D., Weisdorfm, D., Martin, P., Klingemannm, H. G., Beatty, P., Hows, J., Thomas, E. D. (1995). Meeting report: consensus conference on acute GVHD grading. Bone Marrow Transplant. 15: 825–828.
   PubMed Web of Science ®Google Scholar
• Richard, A. P., Erin, D. F., Tuna, M., Tatiana, N. G., Chris, V. K. H., Martina, W., (2001). The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J. Immunol. 167:3223–3230.
   PubMed Web of Science ®Google Scholar
• Sellami, M.H., Ben Ahmed, A., Kaabi, H., Jridi, A., Dridi, A., Hmida, S. (2010) HA-1 and HA-2 minor histocompatibility antigensin Tunisians. Tissue Antigens. [Epub ahead of print]
   PubMedGoogle Scholar
• She, H., Gilman, A.L., Aslanian, S., Shimizu, H., Krailo, M., Chen, Z., (2007). Altered toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease. Biol.Blood Marrow Transplant. 13 386–397.
   PubMed Web of Science ®Google Scholar
• Simpson, E., Scott, D., James, E., Lombardi, G., Cwynarski, K., Dazzin, F., (2002). Minor H antigens: genes and peptides. Transplant Immunol. 10:115–123.
   PubMed Web of Science ®Google Scholar
• Spellman, S., Warden, M. B., Haagenson, M., Pietz, B. C., Goulmy, E., Warren, E. H. (2009). Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol. Blood Marrow Transplant. 15:856–863.
   PubMed Web of Science ®Google Scholar
• Socié, G., Loiseau, P., Tamouza, R., Janin, A., Busson, M., Gluckman, E., (2001). Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 72:699–706.
   PubMed Web of Science ®Google Scholar
• Sun, Y., Tawara, I., Toubai, T., Reddy, P. (2007). Pathophysiology of acute graft-vs-host disease: Recent advances. Translation. Res.150:197–214.
   PubMed Web of Science ®Google Scholar
• Toubai, T., Sun, Y., Reddy, P. (2008). GVHD pathophysiology: Is acute different from chronic? Best Pract. Res. Clin. Haematol. 21:101–117.
   PubMed Web of Science ®Google Scholar
• Tseng, L. H., Lin, M. T., Hansen, J. A., Gooley, T., Pei, J., Smith, A. G., (1999). Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 94:2911–2914.
   PubMed Web of Science ®Google Scholar
• Wilke, M., Pool, J., Goulmy, E. (2002). Allele specific PCR for the minor histocompatibility antigen HA-2. Tissue Antigens 4:304–307.
   Google Scholar